- Thalamus is a leading platform for Graduate Medical Education (GME) and physician recruitment solutions, focused on improving the transition from medical school to residency and ensuring the right doctor is matched with the right hospital.
- In the past year, Thalamus raised $30 million in a Series B funding round on January 30, 2025, and acquired Medicratic on July 30, 2025, to enhance its AI capabilities in medical education.
- The company has established strategic partnerships with over 8,000 medical residency and fellowship programs across 800+ academic institutions, and recently partnered with Trustible to set a new standard for trustworthy AI in academic medicine.
- Thalamus's ideal buyers are medical education programs and healthcare institutions looking to streamline their recruitment processes and improve physician workforce planning, addressing the pressing need for efficient and effective matching in a complex healthcare landscape.
Thalamus operates with a streamlined workforce of 47 employees distributed across three departments. The organizational structure includes a Sales department, Information Technology, and Executive leadership, each comprising one employee. This balanced approach suggests a focus on maintaining a lean operational model, with each department playing a critical role in the company's overall functionality.
The company is headquartered in Santa Clara, California, with a notable presence in Armonk, NY, which houses one employee. Additionally, the 'Other' category accounts for two employees, indicating a distributed workforce model that may support remote work arrangements. This geographic distribution highlights a concentrated operational base while allowing for flexibility in employee locations.
